Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

ClinicalTrials.gov ID: NCT00906204

Public ClinicalTrials.gov record NCT00906204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 6:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose vs. Traditional Administration of Thymoglobulin Induction for Renal Transplantation

Study identification

NCT ID
NCT00906204
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Wright State University
Other
Enrollment
99 participants

Conditions and interventions

Interventions

  • Divided-dose rabbit Anti-thymocyte Globulin induction Biological
  • Single-dose rabbit Anti-thymocyte Globulin induction Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2010
Primary completion
Jun 30, 2014
Completion
Jun 30, 2014
Last update posted
Dec 6, 2015

2010 – 2014

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
University of Nebraska Medical Center Omaha Nebraska 68198
Wake Forest University Winston-Salem North Carolina 27157
The Methodist Hospital Research Institute Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00906204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2015 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00906204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →